OXB
Overview
Join Us in Changing Lives At
OXB , our people are at the heart of everything we do. We’re on a mission to enable life-changing therapies to reach patients around the world—and we’re looking for passionate individuals who embody our core values every day:
Responsible, Responsive, Resilient, and Respectful . The Maintenance Technician IV is responsible for maintaining and supporting facility systems within GMP and non-GMP areas. This role requires strong multi-craft skills (electrical, mechanical, and plumbing) to ensure safe, reliable operation of utilities, equipment, and infrastructure. Responsibilities
Your responsibilities in this role would be: Maintain and operate plant utilities (HVAC, water, steam, electrical, plumbing) per SOPs and GMP standards. Lead and perform maintenance, repairs, and troubleshooting to keep facilities in qualified condition. Support site electrical systems, emergency generators, and distribution. Develop maintenance plans and documentation; ensure traceability and compliance. Supervise contractors and oversee external maintenance activities to meet quality and safety standards. Support risk assessments, audits, and validation activities. Provide on-call and off-shift support as needed. Qualifications
We are Looking For: Strong working knowledge of utilities (HVAC, water systems, compressed air, steam, process gases, etc.). Experience with CMMS, BMS, or SCADA systems. High school diploma or associate degree in a technical discipline. Previous GMP experience preferred. Excellent problem-solving, communication, and teamwork skills. Reliable, proactive, and able to work independently in a fast-paced environment. About Us
OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors—the driving force behind the majority of gene therapies. We collaborate with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Our world-class capabilities span from early-stage development to commercialisation, supported by robust quality-assurance systems, analytical methods, and regulatory expertise. Why Join Us?
Competitive total reward packages Wellbeing programmesthat support your mental and physical health Career development opportunitiesto help you grow and thrive Supportive, inclusive, and collaborative culture State-of-the-art labs and manufacturing facilities A company that lives its values: Responsible, Responsive, Resilient, Respect We want you to feel inspired every day. At OXB, we’re future-focused and growing fast. We succeed together—through passion, commitment, and teamwork. Ready to Make a Difference? Collaborate. Contribute. Change lives.
We offer: Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies. Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy). Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.
#J-18808-Ljbffr
Join Us in Changing Lives At
OXB , our people are at the heart of everything we do. We’re on a mission to enable life-changing therapies to reach patients around the world—and we’re looking for passionate individuals who embody our core values every day:
Responsible, Responsive, Resilient, and Respectful . The Maintenance Technician IV is responsible for maintaining and supporting facility systems within GMP and non-GMP areas. This role requires strong multi-craft skills (electrical, mechanical, and plumbing) to ensure safe, reliable operation of utilities, equipment, and infrastructure. Responsibilities
Your responsibilities in this role would be: Maintain and operate plant utilities (HVAC, water, steam, electrical, plumbing) per SOPs and GMP standards. Lead and perform maintenance, repairs, and troubleshooting to keep facilities in qualified condition. Support site electrical systems, emergency generators, and distribution. Develop maintenance plans and documentation; ensure traceability and compliance. Supervise contractors and oversee external maintenance activities to meet quality and safety standards. Support risk assessments, audits, and validation activities. Provide on-call and off-shift support as needed. Qualifications
We are Looking For: Strong working knowledge of utilities (HVAC, water systems, compressed air, steam, process gases, etc.). Experience with CMMS, BMS, or SCADA systems. High school diploma or associate degree in a technical discipline. Previous GMP experience preferred. Excellent problem-solving, communication, and teamwork skills. Reliable, proactive, and able to work independently in a fast-paced environment. About Us
OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors—the driving force behind the majority of gene therapies. We collaborate with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Our world-class capabilities span from early-stage development to commercialisation, supported by robust quality-assurance systems, analytical methods, and regulatory expertise. Why Join Us?
Competitive total reward packages Wellbeing programmesthat support your mental and physical health Career development opportunitiesto help you grow and thrive Supportive, inclusive, and collaborative culture State-of-the-art labs and manufacturing facilities A company that lives its values: Responsible, Responsive, Resilient, Respect We want you to feel inspired every day. At OXB, we’re future-focused and growing fast. We succeed together—through passion, commitment, and teamwork. Ready to Make a Difference? Collaborate. Contribute. Change lives.
We offer: Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies. Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy). Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.
#J-18808-Ljbffr